Prostate cancer is the most frequent male cancer, accounting for 200 000 new cases every year. The PROSPER initiative investigated the expression and impact of non-coding RNAs on prostate cancer development and progression to improve diagnostics and identify new therapeutic targets.
Further information: cordis.europa.eu